Haris Majstorovic studied pharmacy at the University of Montenegro and graduated with a PharmD degree in 2023.

In January 2024, he joined the research group of Prof. Dr. Alexander Titz at Saarland University and Helmholtz Institute for Pharmaceutical Research Saarland as a master's student. During his master's project, his research focused on the chemical synthesis of fucosyl amides as inhibitors of Pseudomonas aeruginosa LecB, and he defended his master's thesis in November 2024.

In February 2025, he joined the Molecular Pharmacy research group as a PhD student under the supervision of Dr. Rachel Hevey and Prof. Dr. Daniel Ricklin. His research focuses on the synthesis and biological evaluation of mucin glycans for the development of glycan-based antimicrobial therapies.